The global market for Rabies Immune Globulin (Equine) was estimated to be worth US$ 1200 million in 2023 and is forecast to a readjusted size of US$ 1526.7 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030

Rabies Immune Globulin (Equine) - Market

Rabies Immune Globulin (Equine) is a medication used to prevent rabies infection in people who have been exposed to the virus. It is made from the blood of horses that have been immunized against rabies.

The development of Rabies Immune Globulin (Equine) involved the isolation and purification of antibodies from the blood of immunized horses. The process includes collecting blood from the horses, separating the plasma from the red blood cells, and purifying the antibodies using various techniques.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rabies Immune Globulin (Equine), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Rabies Immune Globulin (Equine) by region & country, by Type, and by Application.

The Rabies Immune Globulin (Equine) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Immune Globulin (Equine).

Market Segmentation

Scope of Rabies Immune Globulin (Equine) - Market Report

Report Metric	Details
Report Name	Rabies Immune Globulin (Equine) - Market
Forecasted market size in 2030	US$ 1526.7 million
CAGR	3.5%
Forecasted years	2024 - 2030
Segment by Type:	1500IU 1000IU 400IU Others
Segment by Application	Clinic Hospital
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Grifols, Serum China, Premium Serums, Intas, Aventis Pasteur India, Cadila Pharmaceuticals, Zydus Takeda Healthcare, Bharat Serums And Vaccines, GlaxoSmithKline GmbH, VINS Bioproducts, CSL Behring
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Rabies Immune Globulin (Equine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Rabies Immune Globulin (Equine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Rabies Immune Globulin (Equine) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Rabies Immune Globulin (Equine) - Market size in 2030?

Ans: The Rabies Immune Globulin (Equine) - Market size in 2030 will be US$ 1526.7 million.

Who are the main players in the Rabies Immune Globulin (Equine) - Market report?

Ans: The main players in the Rabies Immune Globulin (Equine) - Market are Grifols, Serum China, Premium Serums, Intas, Aventis Pasteur India, Cadila Pharmaceuticals, Zydus Takeda Healthcare, Bharat Serums And Vaccines, GlaxoSmithKline GmbH, VINS Bioproducts, CSL Behring

What are the Application segmentation covered in the Rabies Immune Globulin (Equine) - Market report?

Ans: The Applications covered in the Rabies Immune Globulin (Equine) - Market report are Clinic, Hospital

What are the Type segmentation covered in the Rabies Immune Globulin (Equine) - Market report?

Ans: The Types covered in the Rabies Immune Globulin (Equine) - Market report are 1500IU, 1000IU, 400IU, Others

1 Market Overview

1.1 Rabies Immune Globulin (Equine) Product Introduction

1.2 Global Rabies Immune Globulin (Equine) Market Size Forecast

1.2.1 Global Rabies Immune Globulin (Equine) Sales Value (2019-2030)

1.2.2 Global Rabies Immune Globulin (Equine) Sales Volume (2019-2030)

1.2.3 Global Rabies Immune Globulin (Equine) Sales Price (2019-2030)

1.3 Rabies Immune Globulin (Equine) Market Trends & Drivers

1.3.1 Rabies Immune Globulin (Equine) Industry Trends

1.3.2 Rabies Immune Globulin (Equine) Market Drivers & Opportunity

1.3.3 Rabies Immune Globulin (Equine) Market Challenges

1.3.4 Rabies Immune Globulin (Equine) Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Rabies Immune Globulin (Equine) Players Revenue Ranking (2023)

2.2 Global Rabies Immune Globulin (Equine) Revenue by Company (2019-2024)

2.3 Global Rabies Immune Globulin (Equine) Players Sales Volume Ranking (2023)

2.4 Global Rabies Immune Globulin (Equine) Sales Volume by Company Players (2019-2024)

2.5 Global Rabies Immune Globulin (Equine) Average Price by Company (2019-2024)

2.6 Key Manufacturers Rabies Immune Globulin (Equine) Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Rabies Immune Globulin (Equine) Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Rabies Immune Globulin (Equine)

2.9 Rabies Immune Globulin (Equine) Market Competitive Analysis

2.9.1 Rabies Immune Globulin (Equine) Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Rabies Immune Globulin (Equine) Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin (Equine) as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 1500IU

3.1.2 1000IU

3.1.3 400IU

3.1.4 Others

3.2 Global Rabies Immune Globulin (Equine) Sales Value by Type

3.2.1 Global Rabies Immune Globulin (Equine) Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Rabies Immune Globulin (Equine) Sales Value, by Type (2019-2030)

3.2.3 Global Rabies Immune Globulin (Equine) Sales Value, by Type (%) (2019-2030)

3.3 Global Rabies Immune Globulin (Equine) Sales Volume by Type

3.3.1 Global Rabies Immune Globulin (Equine) Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Rabies Immune Globulin (Equine) Sales Volume, by Type (2019-2030)

3.3.3 Global Rabies Immune Globulin (Equine) Sales Volume, by Type (%) (2019-2030)

3.4 Global Rabies Immune Globulin (Equine) Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Clinic

4.1.2 Hospital

4.2 Global Rabies Immune Globulin (Equine) Sales Value by Application

4.2.1 Global Rabies Immune Globulin (Equine) Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Rabies Immune Globulin (Equine) Sales Value, by Application (2019-2030)

4.2.3 Global Rabies Immune Globulin (Equine) Sales Value, by Application (%) (2019-2030)

4.3 Global Rabies Immune Globulin (Equine) Sales Volume by Application

4.3.1 Global Rabies Immune Globulin (Equine) Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Rabies Immune Globulin (Equine) Sales Volume, by Application (2019-2030)

4.3.3 Global Rabies Immune Globulin (Equine) Sales Volume, by Application (%) (2019-2030)

4.4 Global Rabies Immune Globulin (Equine) Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Rabies Immune Globulin (Equine) Sales Value by Region

5.1.1 Global Rabies Immune Globulin (Equine) Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Rabies Immune Globulin (Equine) Sales Value by Region (2019-2024)

5.1.3 Global Rabies Immune Globulin (Equine) Sales Value by Region (2025-2030)

5.1.4 Global Rabies Immune Globulin (Equine) Sales Value by Region (%), (2019-2030)

5.2 Global Rabies Immune Globulin (Equine) Sales Volume by Region

5.2.1 Global Rabies Immune Globulin (Equine) Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Rabies Immune Globulin (Equine) Sales Volume by Region (2019-2024)

5.2.3 Global Rabies Immune Globulin (Equine) Sales Volume by Region (2025-2030)

5.2.4 Global Rabies Immune Globulin (Equine) Sales Volume by Region (%), (2019-2030)

5.3 Global Rabies Immune Globulin (Equine) Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Rabies Immune Globulin (Equine) Sales Value, 2019-2030

5.4.2 North America Rabies Immune Globulin (Equine) Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Rabies Immune Globulin (Equine) Sales Value, 2019-2030

5.5.2 Europe Rabies Immune Globulin (Equine) Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Rabies Immune Globulin (Equine) Sales Value, 2019-2030

5.6.2 Asia Pacific Rabies Immune Globulin (Equine) Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Rabies Immune Globulin (Equine) Sales Value, 2019-2030

5.7.2 South America Rabies Immune Globulin (Equine) Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Rabies Immune Globulin (Equine) Sales Value, 2019-2030

5.8.2 Middle East & Africa Rabies Immune Globulin (Equine) Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Rabies Immune Globulin (Equine) Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Rabies Immune Globulin (Equine) Sales Value

6.2.1 Key Countries/Regions Rabies Immune Globulin (Equine) Sales Value, 2019-2030

6.2.2 Key Countries/Regions Rabies Immune Globulin (Equine) Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Rabies Immune Globulin (Equine) Sales Value, 2019-2030

6.3.2 United States Rabies Immune Globulin (Equine) Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Rabies Immune Globulin (Equine) Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Rabies Immune Globulin (Equine) Sales Value, 2019-2030

6.4.2 Europe Rabies Immune Globulin (Equine) Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Rabies Immune Globulin (Equine) Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Rabies Immune Globulin (Equine) Sales Value, 2019-2030

6.5.2 China Rabies Immune Globulin (Equine) Sales Value by Type (%), 2023 VS 2030

6.5.3 China Rabies Immune Globulin (Equine) Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Rabies Immune Globulin (Equine) Sales Value, 2019-2030

6.6.2 Japan Rabies Immune Globulin (Equine) Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Rabies Immune Globulin (Equine) Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Rabies Immune Globulin (Equine) Sales Value, 2019-2030

6.7.2 South Korea Rabies Immune Globulin (Equine) Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Rabies Immune Globulin (Equine) Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Rabies Immune Globulin (Equine) Sales Value, 2019-2030

6.8.2 Southeast Asia Rabies Immune Globulin (Equine) Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Rabies Immune Globulin (Equine) Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Rabies Immune Globulin (Equine) Sales Value, 2019-2030

6.9.2 India Rabies Immune Globulin (Equine) Sales Value by Type (%), 2023 VS 2030

6.9.3 India Rabies Immune Globulin (Equine) Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Grifols

7.1.1 Grifols Company Information

7.1.2 Grifols Introduction and Business Overview

7.1.3 Grifols Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Grifols Rabies Immune Globulin (Equine) Product Offerings

7.1.5 Grifols Recent Development

7.2 Serum China

7.2.1 Serum China Company Information

7.2.2 Serum China Introduction and Business Overview

7.2.3 Serum China Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Serum China Rabies Immune Globulin (Equine) Product Offerings

7.2.5 Serum China Recent Development

7.3 Premium Serums

7.3.1 Premium Serums Company Information

7.3.2 Premium Serums Introduction and Business Overview

7.3.3 Premium Serums Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Premium Serums Rabies Immune Globulin (Equine) Product Offerings

7.3.5 Premium Serums Recent Development

7.4 Intas

7.4.1 Intas Company Information

7.4.2 Intas Introduction and Business Overview

7.4.3 Intas Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Intas Rabies Immune Globulin (Equine) Product Offerings

7.4.5 Intas Recent Development

7.5 Aventis Pasteur India

7.5.1 Aventis Pasteur India Company Information

7.5.2 Aventis Pasteur India Introduction and Business Overview

7.5.3 Aventis Pasteur India Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Aventis Pasteur India Rabies Immune Globulin (Equine) Product Offerings

7.5.5 Aventis Pasteur India Recent Development

7.6 Cadila Pharmaceuticals

7.6.1 Cadila Pharmaceuticals Company Information

7.6.2 Cadila Pharmaceuticals Introduction and Business Overview

7.6.3 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Offerings

7.6.5 Cadila Pharmaceuticals Recent Development

7.7 Zydus Takeda Healthcare

7.7.1 Zydus Takeda Healthcare Company Information

7.7.2 Zydus Takeda Healthcare Introduction and Business Overview

7.7.3 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Offerings

7.7.5 Zydus Takeda Healthcare Recent Development

7.8 Bharat Serums And Vaccines

7.8.1 Bharat Serums And Vaccines Company Information

7.8.2 Bharat Serums And Vaccines Introduction and Business Overview

7.8.3 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Offerings

7.8.5 Bharat Serums And Vaccines Recent Development

7.9 GlaxoSmithKline GmbH

7.9.1 GlaxoSmithKline GmbH Company Information

7.9.2 GlaxoSmithKline GmbH Introduction and Business Overview

7.9.3 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2019-2024)

7.9.4 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Offerings

7.9.5 GlaxoSmithKline GmbH Recent Development

7.10 VINS Bioproducts

7.10.1 VINS Bioproducts Company Information

7.10.2 VINS Bioproducts Introduction and Business Overview

7.10.3 VINS Bioproducts Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2019-2024)

7.10.4 VINS Bioproducts Rabies Immune Globulin (Equine) Product Offerings

7.10.5 VINS Bioproducts Recent Development

7.11 CSL Behring

7.11.1 CSL Behring Company Information

7.11.2 CSL Behring Introduction and Business Overview

7.11.3 CSL Behring Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2019-2024)

7.11.4 CSL Behring Rabies Immune Globulin (Equine) Product Offerings

7.11.5 CSL Behring Recent Development

8 Industry Chain Analysis

8.1 Rabies Immune Globulin (Equine) Industrial Chain

8.2 Rabies Immune Globulin (Equine) Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Rabies Immune Globulin (Equine) Sales Model

8.5.2 Sales Channel

8.5.3 Rabies Immune Globulin (Equine) Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Cadila Pharmaceuticals

Zydus Takeda Healthcare

Bharat Serums and Vaccines

GlaxoSmithKline PLC

Vins Bioproducts

CSL Behring

Aventis Pasteur India

List of Tables

Table 1. Rabies Immune Globulin (Equine) Market Trends

Table 2. Rabies Immune Globulin (Equine) Market Drivers & Opportunity

Table 3. Rabies Immune Globulin (Equine) Market Challenges

Table 4. Rabies Immune Globulin (Equine) Market Restraints

Table 5. Global Rabies Immune Globulin (Equine) Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Rabies Immune Globulin (Equine) Revenue Market Share by Company (2019-2024)

Table 7. Global Rabies Immune Globulin (Equine) Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Rabies Immune Globulin (Equine) Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Rabies Immune Globulin (Equine) Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Rabies Immune Globulin (Equine) Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Rabies Immune Globulin (Equine) Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Rabies Immune Globulin (Equine)

Table 13. Global Rabies Immune Globulin (Equine) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin (Equine) as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Rabies Immune Globulin (Equine) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Rabies Immune Globulin (Equine) Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Rabies Immune Globulin (Equine) Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Rabies Immune Globulin (Equine) Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Rabies Immune Globulin (Equine) Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Rabies Immune Globulin (Equine) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Rabies Immune Globulin (Equine) Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Rabies Immune Globulin (Equine) Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Rabies Immune Globulin (Equine) Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Rabies Immune Globulin (Equine) Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Rabies Immune Globulin (Equine) Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Rabies Immune Globulin (Equine) Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Rabies Immune Globulin (Equine) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Rabies Immune Globulin (Equine) Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Rabies Immune Globulin (Equine) Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Rabies Immune Globulin (Equine) Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Rabies Immune Globulin (Equine) Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Rabies Immune Globulin (Equine) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Rabies Immune Globulin (Equine) Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Rabies Immune Globulin (Equine) Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Rabies Immune Globulin (Equine) Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Rabies Immune Globulin (Equine) Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Rabies Immune Globulin (Equine) Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Rabies Immune Globulin (Equine) Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Rabies Immune Globulin (Equine) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Rabies Immune Globulin (Equine) Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Rabies Immune Globulin (Equine) Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Rabies Immune Globulin (Equine) Sales Value by Region (2019-2024) & (%)

Table 44. Global Rabies Immune Globulin (Equine) Sales Value by Region (2025-2030) & (%)

Table 45. Global Rabies Immune Globulin (Equine) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Rabies Immune Globulin (Equine) Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Rabies Immune Globulin (Equine) Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Rabies Immune Globulin (Equine) Sales Volume by Region (2019-2024) & (%)

Table 49. Global Rabies Immune Globulin (Equine) Sales Volume by Region (2025-2030) & (%)

Table 50. Global Rabies Immune Globulin (Equine) Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Rabies Immune Globulin (Equine) Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Rabies Immune Globulin (Equine) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Rabies Immune Globulin (Equine) Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Rabies Immune Globulin (Equine) Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Rabies Immune Globulin (Equine) Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Rabies Immune Globulin (Equine) Sales Volume, (2025-2030) & (K Units)

Table 57. Grifols Company Information

Table 58. Grifols Introduction and Business Overview

Table 59. Grifols Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Grifols Rabies Immune Globulin (Equine) Product Offerings

Table 61. Grifols Recent Development

Table 62. Serum China Company Information

Table 63. Serum China Introduction and Business Overview

Table 64. Serum China Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Serum China Rabies Immune Globulin (Equine) Product Offerings

Table 66. Serum China Recent Development

Table 67. Premium Serums Company Information

Table 68. Premium Serums Introduction and Business Overview

Table 69. Premium Serums Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Premium Serums Rabies Immune Globulin (Equine) Product Offerings

Table 71. Premium Serums Recent Development

Table 72. Intas Company Information

Table 73. Intas Introduction and Business Overview

Table 74. Intas Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Intas Rabies Immune Globulin (Equine) Product Offerings

Table 76. Intas Recent Development

Table 77. Aventis Pasteur India Company Information

Table 78. Aventis Pasteur India Introduction and Business Overview

Table 79. Aventis Pasteur India Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Aventis Pasteur India Rabies Immune Globulin (Equine) Product Offerings

Table 81. Aventis Pasteur India Recent Development

Table 82. Cadila Pharmaceuticals Company Information

Table 83. Cadila Pharmaceuticals Introduction and Business Overview

Table 84. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Offerings

Table 86. Cadila Pharmaceuticals Recent Development

Table 87. Zydus Takeda Healthcare Company Information

Table 88. Zydus Takeda Healthcare Introduction and Business Overview

Table 89. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Offerings

Table 91. Zydus Takeda Healthcare Recent Development

Table 92. Bharat Serums And Vaccines Company Information

Table 93. Bharat Serums And Vaccines Introduction and Business Overview

Table 94. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Offerings

Table 96. Bharat Serums And Vaccines Recent Development

Table 97. GlaxoSmithKline GmbH Company Information

Table 98. GlaxoSmithKline GmbH Introduction and Business Overview

Table 99. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Offerings

Table 101. GlaxoSmithKline GmbH Recent Development

Table 102. VINS Bioproducts Company Information

Table 103. VINS Bioproducts Introduction and Business Overview

Table 104. VINS Bioproducts Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. VINS Bioproducts Rabies Immune Globulin (Equine) Product Offerings

Table 106. VINS Bioproducts Recent Development

Table 107. CSL Behring Company Information

Table 108. CSL Behring Introduction and Business Overview

Table 109. CSL Behring Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. CSL Behring Rabies Immune Globulin (Equine) Product Offerings

Table 111. CSL Behring Recent Development

Table 112. Key Raw Materials Lists

Table 113. Raw Materials Key Suppliers Lists

Table 114. Rabies Immune Globulin (Equine) Downstream Customers

Table 115. Rabies Immune Globulin (Equine) Distributors List

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Rabies Immune Globulin (Equine) Product Picture

Figure 2. Global Rabies Immune Globulin (Equine) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Rabies Immune Globulin (Equine) Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Rabies Immune Globulin (Equine) Sales Volume (2019-2030) & (K Units)

Figure 5. Global Rabies Immune Globulin (Equine) Sales Price (2019-2030) & (US$/Unit)

Figure 6. Rabies Immune Globulin (Equine) Report Years Considered

Figure 7. Global Rabies Immune Globulin (Equine) Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Rabies Immune Globulin (Equine) Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Rabies Immune Globulin (Equine) Revenue in 2023

Figure 10. Rabies Immune Globulin (Equine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. 1500IU Picture

Figure 12. 1000IU Picture

Figure 13. 400IU Picture

Figure 14. Others Picture

Figure 15. Global Rabies Immune Globulin (Equine) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Rabies Immune Globulin (Equine) Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Rabies Immune Globulin (Equine) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Rabies Immune Globulin (Equine) Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Rabies Immune Globulin (Equine) Price by Type (2019-2030) & (US$/Unit)

Figure 20. Product Picture of Clinic

Figure 21. Product Picture of Hospital

Figure 22. Global Rabies Immune Globulin (Equine) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Rabies Immune Globulin (Equine) Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Rabies Immune Globulin (Equine) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Rabies Immune Globulin (Equine) Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Rabies Immune Globulin (Equine) Price by Application (2019-2030) & (US$/Unit)

Figure 27. North America Rabies Immune Globulin (Equine) Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Rabies Immune Globulin (Equine) Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Rabies Immune Globulin (Equine) Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Rabies Immune Globulin (Equine) Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Rabies Immune Globulin (Equine) Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Rabies Immune Globulin (Equine) Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Rabies Immune Globulin (Equine) Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Rabies Immune Globulin (Equine) Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Rabies Immune Globulin (Equine) Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Rabies Immune Globulin (Equine) Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Rabies Immune Globulin (Equine) Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Rabies Immune Globulin (Equine) Sales Volume (%), (2019-2030)

Figure 39. United States Rabies Immune Globulin (Equine) Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Rabies Immune Globulin (Equine) Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Rabies Immune Globulin (Equine) Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Rabies Immune Globulin (Equine) Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Rabies Immune Globulin (Equine) Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Rabies Immune Globulin (Equine) Sales Value by Application (%), 2023 VS 2030

Figure 45. China Rabies Immune Globulin (Equine) Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Rabies Immune Globulin (Equine) Sales Value by Type (%), 2023 VS 2030

Figure 47. China Rabies Immune Globulin (Equine) Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Rabies Immune Globulin (Equine) Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Rabies Immune Globulin (Equine) Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Rabies Immune Globulin (Equine) Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Rabies Immune Globulin (Equine) Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Rabies Immune Globulin (Equine) Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Rabies Immune Globulin (Equine) Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Rabies Immune Globulin (Equine) Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Rabies Immune Globulin (Equine) Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Rabies Immune Globulin (Equine) Sales Value by Application (%), 2023 VS 2030

Figure 57. India Rabies Immune Globulin (Equine) Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Rabies Immune Globulin (Equine) Sales Value by Type (%), 2023 VS 2030

Figure 59. India Rabies Immune Globulin (Equine) Sales Value by Application (%), 2023 VS 2030

Figure 60. Rabies Immune Globulin (Equine) Industrial Chain

Figure 61. Rabies Immune Globulin (Equine) Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions